The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a series of new rules from the Centers for Medicare & Medicaid Services (CMS). Earlier ...
Sept. 17, 2026 — Merge has launched MergeIQ, an artificial intelligence layer that embeds practical intelligence ...
Sept. 15, 2026 — The Food & Drug Administration has approved Abbott’s AVEIR VR Mini Ventricular leadless pacemaker (LP) ...
Sept. 14, 2026 — Interventional Medical Device Solutions (IMDS), has announced the U.S. launch of NHanceIT, an over-the ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Sept. 8, 2026 — Penumbra recently launched the Link clot capture device designed to support the removal of arterial ...
The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a ...
Sept. 9, 2026— Atman Health has been selected by the Advanced Research Projects Agency for Health (ARPA-H) to develop an ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Sept. 9, 2026 —The Nicklaus Children's Hospital Heart Institute has successfully performed one of the first Fontan ...
Aug. 29, 2026— Vesalio recently announced results from the NATURE trial (NCT04969471), a prospective, randomized ...
Sept. 8, 2026 — New research1 indicates that people with invasive cancer face an elevated risk of experiencing a stroke ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Aug. 27, 2026 — Artificial intelligence is fundamentally reshaping the cardiovascular devices landscape, driven by a ...
Sept. 8, 2026 — Abbot has announced that it has received U.S. Food and Drug Administration (FDA) approval for the ...
Sept. 2, 2026 — Heartvue.ai and Innolitics have announced the U.S. Food and Drug Administration has granted 510(k) ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Aug. 31, 2026 — Caristo Diagnostics has announced new independent University of Oxford-led research showing that Caristo ...
Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...
Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...
September 21, 2026
